Omnicell Operating Income from 2010 to 2026

OMCL Stock

USD 41.37 1.22 3.04%

Omnicell Operating Income yearly trend continues to be quite stable with very little volatility. The value of Operating Income is projected to decrease to about 4.9 M. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Omnicell generates from its operations. View All Fundamentals

Operating Income

First Reported

2000-03-31

Previous Quarter

8.2 M

Current Value

415 K

Quarterly Volatility

9.9 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Omnicell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnicell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 82.7 M, Interest Expense of 3.5 M or Selling General Administrative of 459.2 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 1.61. Omnicell financial statements analysis is a perfect complement when working with Omnicell Valuation or Volatility modules.

Build AI portfolio with Omnicell Stock

Check out the analysis of Omnicell Correlation against competitors.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Historical Operating Income data for Omnicell serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Omnicell represents a compelling investment opportunity.

Latest Omnicell's Operating Income Growth Pattern

Below is the plot of the Operating Income of Omnicell over the last few years. Operating Income is the amount of profit realized from Omnicell operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Omnicell is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Omnicell's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omnicell's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Operating Income

Timeline

Omnicell Operating Income Regression Statistics

	Arithmetic Mean	22,970,941
	Coefficient Of Variation	142.77
	Mean Deviation	26,424,291
	Median	16,222,000
	Standard Deviation	32,794,621
	Sample Variance	1075.5T
	Range	124.4M
	R-Value	(0.13)
	Mean Square Error	1127.4T
	R-Squared	0.02
	Significance	0.62
	Slope	(851,902)
	Total Sum of Squares	17207.8T

Omnicell Operating Income History

	2026	4.9 M
	2025	5.2 M
	2024	337 K
	2023	-34.9 M
	2022	-2.3 M
	2021	89.5 M
	2020	35.5 M

Other Fundumenentals of Omnicell

Non Operating Income Net Other

Omnicell Operating Income component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Good Will	Intangible Assets	Treasury Stock	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.96	0.6	0.97	0.82	0.8	0.86	0.71	0.97	0.92	0.56	-0.4	0.95	0.99	0.85	-0.95	0.13	0.94	-0.42	0.77	0.81	0.56	0.74	0.47	0.75
Total Stockholder Equity	0.98		0.96	0.47	0.99	0.78	0.68	0.82	0.7	0.91	0.87	0.58	-0.45	0.96	0.97	0.77	-0.93	0.18	0.93	-0.45	0.82	0.79	0.58	0.74	0.43	0.8
Current Deferred Revenue	0.96	0.96		0.55	0.96	0.78	0.66	0.82	0.56	0.91	0.83	0.57	-0.41	0.93	0.97	0.77	-0.93	0.05	0.9	-0.42	0.83	0.81	0.45	0.74	0.37	0.79
Net Debt	0.6	0.47	0.55		0.5	0.73	0.8	0.73	0.32	0.73	0.56	0.26	-0.07	0.52	0.63	0.76	-0.63	-0.23	0.56	0.04	0.25	0.36	0.3	0.3	0.22	0.22
Retained Earnings	0.97	0.99	0.96	0.5		0.77	0.67	0.82	0.66	0.9	0.84	0.58	-0.44	0.96	0.97	0.76	-0.93	0.17	0.92	-0.42	0.83	0.78	0.57	0.73	0.42	0.81
Accounts Payable	0.82	0.78	0.78	0.73	0.77		0.77	0.94	0.5	0.84	0.84	0.54	-0.42	0.77	0.8	0.94	-0.81	0.06	0.84	-0.07	0.37	0.46	0.62	0.41	0.15	0.43
Long Term Debt	0.8	0.68	0.66	0.8	0.67	0.77		0.76	0.64	0.9	0.85	0.38	-0.22	0.68	0.76	0.88	-0.75	0.05	0.74	-0.22	0.34	0.63	0.48	0.5	0.46	0.38
Net Receivables	0.86	0.82	0.82	0.73	0.82	0.94	0.76		0.64	0.87	0.89	0.34	-0.43	0.75	0.83	0.91	-0.9	0.08	0.89	-0.17	0.5	0.47	0.58	0.61	0.39	0.49
Short Term Investments	0.71	0.7	0.56	0.32	0.66	0.5	0.64	0.64		0.7	0.78	0.21	-0.16	0.62	0.67	0.55	-0.66	0.16	0.74	-0.51	0.57	0.56	0.44	0.71	0.59	0.56
Total Liab	0.97	0.91	0.91	0.73	0.9	0.84	0.9	0.87	0.7		0.93	0.52	-0.32	0.89	0.96	0.9	-0.93	0.08	0.91	-0.38	0.67	0.79	0.52	0.7	0.48	0.66
Total Current Assets	0.92	0.87	0.83	0.56	0.84	0.84	0.85	0.89	0.78	0.93		0.4	-0.41	0.79	0.86	0.89	-0.89	0.21	0.93	-0.4	0.55	0.68	0.56	0.73	0.54	0.59
Short Term Debt	0.56	0.58	0.57	0.26	0.58	0.54	0.38	0.34	0.21	0.52	0.4		-0.14	0.74	0.61	0.49	-0.43	-0.13	0.53	-0.02	0.43	0.62	0.4	0.05	-0.39	0.54
Common Stock	-0.4	-0.45	-0.41	-0.07	-0.44	-0.42	-0.22	-0.43	-0.16	-0.32	-0.41	-0.14		-0.4	-0.36	-0.4	0.43	0.01	-0.31	-0.07	-0.2	-0.15	-0.22	-0.18	-0.12	-0.17
Property Plant Equipment	0.95	0.96	0.93	0.52	0.96	0.77	0.68	0.75	0.62	0.89	0.79	0.74	-0.4		0.97	0.76	-0.87	-0.02	0.88	-0.36	0.79	0.84	0.49	0.62	0.24	0.81
Good Will	0.99	0.97	0.97	0.63	0.97	0.8	0.76	0.83	0.67	0.96	0.86	0.61	-0.36	0.97		0.81	-0.94	0.02	0.92	-0.41	0.82	0.84	0.49	0.72	0.39	0.8
Intangible Assets	0.85	0.77	0.77	0.76	0.76	0.94	0.88	0.91	0.55	0.9	0.89	0.49	-0.4	0.76	0.81		-0.83	0.12	0.83	-0.08	0.35	0.52	0.62	0.44	0.29	0.38
Treasury Stock	-0.95	-0.93	-0.93	-0.63	-0.93	-0.81	-0.75	-0.9	-0.66	-0.93	-0.89	-0.43	0.43	-0.87	-0.94	-0.83		-0.06	-0.91	0.33	-0.75	-0.73	-0.47	-0.76	-0.5	-0.69
Net Tangible Assets	0.13	0.18	0.05	-0.23	0.17	0.06	0.05	0.08	0.16	0.08	0.21	-0.13	0.01	-0.02	0.02	0.12	-0.06		0.17	-0.26	-0.02	-0.08	0.61	0.17	0.44	0.0
Capital Surpluse	0.94	0.93	0.9	0.56	0.92	0.84	0.74	0.89	0.74	0.91	0.93	0.53	-0.31	0.88	0.92	0.83	-0.91	0.17		-0.43	0.71	0.74	0.59	0.77	0.43	0.79
Deferred Long Term Liab	-0.42	-0.45	-0.42	0.04	-0.42	-0.07	-0.22	-0.17	-0.51	-0.38	-0.4	-0.02	-0.07	-0.36	-0.41	-0.08	0.33	-0.26	-0.43		-0.59	-0.6	-0.06	-0.75	-0.62	-0.58
Long Term Investments	0.77	0.82	0.83	0.25	0.83	0.37	0.34	0.5	0.57	0.67	0.55	0.43	-0.2	0.79	0.82	0.35	-0.75	-0.02	0.71	-0.59		0.81	0.17	0.81	0.42	0.92
Long Term Debt Total	0.81	0.79	0.81	0.36	0.78	0.46	0.63	0.47	0.56	0.79	0.68	0.62	-0.15	0.84	0.84	0.52	-0.73	-0.08	0.74	-0.6	0.81		0.16	0.72	0.36	0.85
Short Long Term Debt	0.56	0.58	0.45	0.3	0.57	0.62	0.48	0.58	0.44	0.52	0.56	0.4	-0.22	0.49	0.49	0.62	-0.47	0.61	0.59	-0.06	0.17	0.16		0.19	0.18	0.23
Net Invested Capital	0.74	0.74	0.74	0.3	0.73	0.41	0.5	0.61	0.71	0.7	0.73	0.05	-0.18	0.62	0.72	0.44	-0.76	0.17	0.77	-0.75	0.81	0.72	0.19		0.79	0.79
Net Working Capital	0.47	0.43	0.37	0.22	0.42	0.15	0.46	0.39	0.59	0.48	0.54	-0.39	-0.12	0.24	0.39	0.29	-0.5	0.44	0.43	-0.62	0.42	0.36	0.18	0.79		0.33
Capital Stock	0.75	0.8	0.79	0.22	0.81	0.43	0.38	0.49	0.56	0.66	0.59	0.54	-0.17	0.81	0.8	0.38	-0.69	0.0	0.79	-0.58	0.92	0.85	0.23	0.79	0.33

Click cells to compare fundamentals

About Omnicell Financial Statements

Omnicell investors utilize fundamental indicators, such as Operating Income, to predict how Omnicell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Operating Income	5.2 M	4.9 M
Non Operating Income Net Other	-117 K	-122.8 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:

How To Invest In Omnicell

Details

Is Omnicell Stock a good investment?

Details

What is Omnicell's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Omnicell Correlation against competitors.

For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. Anticipated expansion of Omnicell directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Omnicell assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Quarterly Earnings Growth

(0.36)

Earnings Share

0.04

Revenue Per Share

25.777

Quarterly Revenue Growth

0.023

Return On Assets

0.003

Understanding Omnicell requires distinguishing between market price and book value, where the latter reflects Omnicell's accounting equity. The concept of intrinsic value - what Omnicell's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Omnicell's price substantially above or below its fundamental value.

It's important to distinguish between Omnicell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omnicell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Omnicell's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Omnicell Operating Income from 2010 to 2026

Latest Omnicell's Operating Income Growth Pattern

Omnicell Operating Income Regression Statistics

Omnicell Operating Income History

Other Fundumenentals of Omnicell

Omnicell Operating Income component correlations

About Omnicell Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY